CN101816757A - Chinese medicinal composition for treating antiaditis and preparation method thereof - Google Patents
Chinese medicinal composition for treating antiaditis and preparation method thereof Download PDFInfo
- Publication number
- CN101816757A CN101816757A CN201010189963A CN201010189963A CN101816757A CN 101816757 A CN101816757 A CN 101816757A CN 201010189963 A CN201010189963 A CN 201010189963A CN 201010189963 A CN201010189963 A CN 201010189963A CN 101816757 A CN101816757 A CN 101816757A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- rhizoma
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a novel Chinese medicinal composition for treating antiaditis and a preparation method thereof. The Chinese medicinal composition mainly comprises the following raw material medicaments: blackberrykiky rhizome, immature bitter orange, Chinese eaglewood, szechuan lovage rhizome, tangerine peel, costustoot, radish seed, szechwan chinaberry fruit, longstamen onion bulb, honey suckle flower, philippine violet herb, mongolian dandelion herb, weeping forsythiae capsule, figwort root, fresh rehmannia, lightyellow sophora root, baical skullcap root, chrysanthemum, bupleurum, kudzuvine root, mint, great burdock achene, gypsum, anemarrhena asphodeloides bunge, common lophatherum herb, mongolian snakegourd root, gentian, heartleaf houttuynia herb, dahurian patrinia herb and the like. The Chinese medicinal composition can be prepared into any one common orally-taken preparation by a conventional Chinese medicinal preparation method. The Chinese medicinal composition can remarkably improve the symptoms: antiaditis, antiadoncus, inflamed and purulent pharynx, ardor and pain, bitter mouth and dry pharynx, dry congh, cough and the like, and has extract clinical treatment effect, remarkable treatment effect and quick response. The Chinese medicinal composition also has the advantages of low cost, basically no toxic or side effect and the like.
Description
Technical field
The present invention relates to the tonsillitic Chinese medicine composition of a kind of treatment.Relating in particular to a kind of is the tonsillitic Chinese medicine composition of treatment and preparation method thereof of crude drug with the Chinese herbal medicine.
Background technology
[0002] tonsillitis is a kind of disease that acute or chronic inflammatory disease take place pharyngeal tonsil, is the Childhood commonly encountered diseases.The opposing of almond physical ability enters the antibacterial in nose and the pharyngeal cavity under the normal condition; human body is played a protective role; but; children's is because passive protective physical fitness is low; add the flu of suffering from cold; the ability of tonsil opposing antibacterial is weakened, thereby cause oral cavity, pharyngeal, nasal cavity and extraneous antibacterial to invade tonsil, be inflamed.The severe patient tonsil is red and swollen to suppurate, and forms suppurative tonsillitis, obstinate can change into chronic tonsillitis, causes systemic disease such as nephritis, heart disease, rheumatism and pigeon chest, funnel chest easily.
Chinese medicine because of its shape like nipple or Bombycis mori, so be called " tonsillitis ", go into to invade lung stomach two warps from mouth and nose mainly due to wind-heat evil toxin, evil poison is fumigated in throat and is satisfied into primary disease; Or the lung stomach have long-pending heat, or pyretic toxicity is more very, the moon of scorching hot lung stomach, and deficiency of body fluid, hyperactivity of deficient fire forms, the Chang Fanfu outbreak.Clinical manifestation is for fever and headache to occur in acute stage, fear of cold, and child Ke Yin hyperpyrexia and cause convulsions, pharyngalgia is obvious, saliva is increased etc., and difficulty can appear opening one's mouth in severe patient, during inspection, as seen tonsil redness, there are faint yellow or white pus point, the common enlargement of mandibular lymph node in the surface; Show as pharyngeal and tonsil flushing in chronic phase, visible yellow color secretions, it is not obvious to have sore throat, and low grade fever is arranged once in a while and is off one's feed etc.The clinical onset rate has very high.
Modern medicine is at clinical a certain symptom treatment, often fall flat, can not find suitable Therapeutic Method, in order to overcome above-mentioned defective, the present invention is based on tonsillitic differential diagnosis of diseases of Chinese traditional treatment and the dialectical principle that combines, treating both the principal and secondary aspects of a disease, deficiency and excess is also controlled, inside and outside logical accent, emergency is taken in concurrently, filter out the natural plant of heat-clearing and toxic substances removing, detumescence sore-throat relieving, nourishing YIN and moistening the lung,, be prepared from according to certain weight proportion according to the theory of Chinese medical science prescription.Provide a kind of treatment evident in efficacy, with low cost, that toxic and side effects is minimum tonsillitic Chinese medicine composition.
Above-mentioned Chinese medicine composition of the present invention adds various conventional adjuvant required when preparing different dosage forms, for example disintegrating agent, lubricant, adhesive etc. are prepared into any oral formulations commonly used with the method for Chinese medicinal of routine, for example can be: pill, capsule, tablet, powder, granule or oral liquid etc.
Summary of the invention
Technical problem to be solved by this invention is assorted to overcome above-described shortcoming, provides a kind of treatment evident in efficacy, with low cost, almost non-toxic side effect tonsillitic Chinese medicine composition.
The technical problem of the desired solution of the present invention realizes by following technological approaches.
The tonsillitic Chinese medicine composition of a kind of treatment of the present invention, the component of main following weight portion is formed:
1～50 part of Rhizoma Belamcandae, 1～150 part of Fructus Aurantii Immaturus, 1～50 part of Lignum Aquilariae Resinatum, 1～50 part of Rhizoma Chuanxiong, 1～100 part on Pericarpium Citri Reticulatae Viride, 1～150 part of Pericarpium Citri Reticulatae, 1～100 part of the Radix Aucklandiae, 1～120 part of Semen Raphani, 1～120 part of Fructus Toosendan, 1～50 part of Semen Canavaliae, 1～100 part of Bulbus Allii Macrostemonis, 1～120 part of Flos Lonicerae, 1～100 part of Herba Violae, 1～120 part of Herba Taraxaci, 1～100 part of Fructus Forsythiae, 1～100 part of Radix Scrophulariae, 1～120 part of Radix Rehmanniae, 1～100 part of Radix Sophorae Flavescentis, 1～120 part of Radix Scutellariae, 1～50 part of Flos Chrysanthemi, 1～100 part of Radix Bupleuri, 1～100 part of Radix Puerariae, 1～30 part of Herba Menthae, 1～100 part of Fructus Arctii, 1～120 part of Gypsum Fibrosum, 1～100 part of the Rhizoma Anemarrhenae, 1～100 part of Herba Lophatheri, 1～120 part of Radix Trichosanthis, 1～100 part of Radix Gentianae, 1～120 part of Herba Houttuyniae, 1～120 part of Cortex Moutan, 1～100 part of Radix Paeoniae Rubra, 1～50 part of Rhizoma Paridis, 1～100 part of Folium Isatidis, 1～100 part of Radix Isatidis, 1～100 part of Indigo Naturalis, 1～100 part of Herba Patriniae, 1～100 part of Radix Sophorae Tonkinensis, 1～120 part of Rhizoma Smilacis Glabrae, 1～50 part of Herba Andrographis, 1～50 part of Herba Lobeliae Chinensis, 1～100 part of Herba Hedyotidis Diffusae.
Be preferably:
15 parts of Rhizoma Belamcandae, 30 parts of Fructus Aurantii Immaturuss, 10 parts of Lignum Aquilariae Resinatum, 20 parts of Rhizoma Chuanxiongs, 30 parts on Pericarpium Citri Reticulatae Viride, 50 parts of Pericarpium Citri Reticulataes, 20 parts of the Radix Aucklandiae, 20 parts of Semen Raphanis, 30 parts of Fructus Toosendans, 15 parts of Semen Canavaliaes, 20 parts of Bulbus Allii Macrostemonis, 30 parts of Flos Loniceraes, 20 parts of Herba Violaes, 30 parts of Herba Taraxacis, 20 parts of Fructus Forsythiaes, 20 parts of Radix Scrophulariaes, 30 parts of Radix Rehmanniae, 30 parts of Radix Sophorae Flavescentiss, 30 parts of Radix Scutellariaes, 15 parts of Flos Chrysanthemis, 20 parts of Radix Bupleuri, 20 parts of Radix Puerariaes, 10 parts of Herba Menthaes, 20 parts of Fructus Arctiis, 50 parts of Gypsum Fibrosum, 20 parts of the Rhizoma Anemarrhenaes, 20 parts of Herba Lophatheris, 30 parts of Radix Trichosanthis, 20 parts of Radix Gentianaes, 30 parts of Herba Houttuyniae, 30 parts of Cortex Moutans, 20 parts of Radix Paeoniae Rubra, 15 parts of Rhizoma Paridis, 20 parts of Folium Isatidiss, 30 parts of Baphicacanthus cusia, 20 parts of Indigo Naturaliss, 20 parts of Herba Patriniae, 20 parts of Radix Sophorae Tonkinensiss, 30 parts of Rhizoma Smilacis Glabraes, 15 parts of Herba Andrographis, 15 parts of Herba Lobeliae Chinensis, 20 parts of Herba Hedyotidis Diffusaes.
The weight portion consumption of each component of Chinese medicine composition of the present invention can also be:
1～50 part of Radix Cynanchi Atrati, 1～120 part of Cortex Lycii, 1～100 part of Radix Stellariae, 1～100 part of Rhizoma Picrorhizae, 1～100 part of Radix Et Rhizoma Rhei, 1～100 part of Semen Pruni, 1～100 part of Radix Curcumae, 1～50 part of rhizoma sparganic, 1～50 part of Rhizoma Curcumae, 1～50 part of Squama Manis, 1～50 part of Carapax Trionycis, 1～50 part of Carapax et Plastrum Testudinis, 1～120 part of Semen Trichosanthis, 1～30 part of Bulbus Fritillariae Uninbracteatae, 1～100 part of the Radix Paeoniae Alba, 1～100 part of Radix Angelicae Sinensis, 1～120 part of Radix Adenophorae (Radix Glehniae), 1～100 part of Radix Ophiopogonis, 1～100 part of Radix Asparagi, 1～100 part of Fructus Lycii, 1～50 part of Herba Dendrobii, 1～50 part of Rhizoma Polygonati Odorati.
Be preferably:
15 parts of Radix Cynanchi Atratis, 30 parts of Cortex Lycii, 20 parts of Radix Stellariaes, 20 parts of Rhizoma Picrorhizae, 20 parts of Radix Et Rhizoma Rhei, 20 parts of Semen Prunis, 20 parts of Radix Curcumaes, 15 parts of rhizoma sparganic, 15 parts of Rhizoma Curcumae, 15 parts of Squama Maniss, 15 parts of Carapax Trionycis, 15 parts of Carapax et Plastrum Testudiniss, 30 parts of Semen Trichosanthis, 10 parts of Bulbus Fritillariae Uninbracteataes, 30 parts of the Radix Paeoniae Albas, 30 parts of Radix Angelicae Sinensis, 30 parts of Radix Adenophorae (Radix Glehniae), 20 parts of Radix Ophiopogonis, 20 parts of Radix Asparagi, 20 parts of Fructus Lycii, 15 parts of Herba Dendrobiis, 15 parts of Rhizoma Polygonati Odorati.
Above-mentioned Chinese medicine composition of the present invention adds various conventional adjuvant required when preparing different dosage form, for example disintegrating agent, lubricant, adhesive etc. are prepared into any oral formulations commonly used with the method for Chinese medicinal of routine, for example can be pill, capsule, tablet, powder, granule or oral liquid etc.
Chinese medicine composition of the present invention is opened one's minds based on traditional Chinese medical science the five internal organs differentiation of syndromes of YIN and YANG guiding principle, in conjunction with safe one and Pu innovation theory system " ten thousand diseases ascent theory ", " the five internal organs differentiation of syndromes of YIN and YANG guiding principle ", " three-dimensional conservation regulation and control rule " and clinical treatment " pairing principle " are as instructing, take place in conjunction with disease, development and the rule that changes, classify according to the original new drug system, formation is monarch with " the five internal organs basic function is adjusted; equilibrium between yin and yang coordination side ", " the main pathogenesis of the five internal organs adjustment side " is minister, " therapy of serious disease side " is assistant, " clinical fundamental symptoms symptomatic treatment side " Chinese medicine patent medicine " original new drug system " for making.
The used herbal raw material medicine of the present invention all can be buied from the Chinese medicine shop, and its specification meets national medical standard.
Usage and dosage: dosage of the present invention depends on concrete dosage form, factors such as patient age, body weight, health status.As guidance: for oral administration: 1) capsule: obey 2～5 every day three times at every turn, every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2～4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 5 grams, warm water takes.4) granule: every day three times.Each 5 grams, warm water takes.
The treatment that the present invention is directed to the tonsillitis patient is very effective, various crude drug are coordinated mutually can play together and are at utmost brought into play drug effect, can effectively improve the self-coordination ability of patient's body, significantly improve function and clinical subjective symptoms, have advantage such as have no side effect, expense is lower in addition.
The specific embodiment
Further describe the present invention by the following examples, it should be understood that these embodiment only are used for the purpose of illustration, never are limited to the present invention.
The preparation of [embodiment 1] capsule
Take by weighing each raw material by following weight portion: 15 parts of Rhizoma Belamcandae, 30 parts of Fructus Aurantii Immaturuss, 10 parts of Lignum Aquilariae Resinatum, 20 parts of Rhizoma Chuanxiongs, 30 parts on Pericarpium Citri Reticulatae Viride, 50 parts of Pericarpium Citri Reticulataes, 20 parts of the Radix Aucklandiae, 20 parts of Semen Raphanis, 30 parts of Fructus Toosendans, 15 parts of Semen Canavaliaes, 20 parts of Bulbus Allii Macrostemonis, 30 parts of Flos Loniceraes, 20 parts of Herba Violaes, 30 parts of Herba Taraxacis, 20 parts of Fructus Forsythiaes, 20 parts of Radix Scrophulariaes, 30 parts of Radix Rehmanniae, 30 parts of Radix Sophorae Flavescentiss, 30 parts of Radix Scutellariaes, 15 parts of Flos Chrysanthemis, 20 parts of Radix Bupleuri, 20 parts of Radix Puerariaes, 10 parts of Herba Menthaes, 20 parts of Fructus Arctiis, 50 parts of Gypsum Fibrosum, 20 parts of the Rhizoma Anemarrhenaes, 20 parts of Herba Lophatheris, 30 parts of Radix Trichosanthis, 20 parts of Radix Gentianaes, 30 parts of Herba Houttuyniae, 30 parts of Cortex Moutans, 20 parts of Radix Paeoniae Rubra, 15 parts of Rhizoma Paridis, 20 parts of Folium Isatidiss, 30 parts of Baphicacanthus cusia, 20 parts of Indigo Naturaliss, 20 parts of Herba Patriniae, 20 parts of Radix Sophorae Tonkinensiss, 30 parts of Rhizoma Smilacis Glabraes, 15 parts of Herba Andrographis, 15 parts of Herba Lobeliae Chinensis, 20 parts of Herba Hedyotidis Diffusaes.
Grind into after each component mixing with above-mentioned weight and incapsulate promptly after fine powder is crossed 1500 mesh sieves.
The preparation of [embodiment 2] granule
Take by weighing each raw material by following weight portion: 15 parts of Rhizoma Belamcandae, 30 parts of Fructus Aurantii Immaturuss, 10 parts of Lignum Aquilariae Resinatum, 20 parts of Rhizoma Chuanxiongs, 30 parts on Pericarpium Citri Reticulatae Viride, 50 parts of Pericarpium Citri Reticulataes, 20 parts of the Radix Aucklandiae, 20 parts of Semen Raphanis, 30 parts of Fructus Toosendans, 15 parts of Semen Canavaliaes, 20 parts of Bulbus Allii Macrostemonis, 30 parts of Flos Loniceraes, 20 parts of Herba Violaes, 30 parts of Herba Taraxacis, 20 parts of Fructus Forsythiaes, 20 parts of Radix Scrophulariaes, 30 parts of Radix Rehmanniae, 30 parts of Radix Sophorae Flavescentiss, 30 parts of Radix Scutellariaes, 15 parts of Flos Chrysanthemis, 20 parts of Radix Bupleuri, 20 parts of Radix Puerariaes, 10 parts of Herba Menthaes, 20 parts of Fructus Arctiis, 50 parts of Gypsum Fibrosum, 20 parts of the Rhizoma Anemarrhenaes, 20 parts of Herba Lophatheris, 30 parts of Radix Trichosanthis, 20 parts of Radix Gentianaes, 30 parts of Herba Houttuyniae, 30 parts of Cortex Moutans, 20 parts of Radix Paeoniae Rubra, 15 parts of Rhizoma Paridis, 20 parts of Folium Isatidiss, 30 parts of Baphicacanthus cusia, 20 parts of Indigo Naturaliss, 20 parts of Herba Patriniae, 20 parts of Radix Sophorae Tonkinensiss, 30 parts of Rhizoma Smilacis Glabraes, 15 parts of Herba Andrographis, 15 parts of Herba Lobeliae Chinensis, 20 parts of Herba Hedyotidis Diffusaes.
Each raw material of above-mentioned weight fraction is mixed, after grinding into fine powder and crossing 1500 mesh sieves, add ethanol and make adhesive, add starch and do filler, be pressed into granule.
The preparation of [embodiment 3] tablet
Take by weighing each raw material by following weight portion: 15 parts of Rhizoma Belamcandae, 30 parts of Fructus Aurantii Immaturuss, 10 parts of Lignum Aquilariae Resinatum, 20 parts of Rhizoma Chuanxiongs, 30 parts on Pericarpium Citri Reticulatae Viride, 50 parts of Pericarpium Citri Reticulataes, 20 parts of the Radix Aucklandiae, 20 parts of Semen Raphanis, 30 parts of Fructus Toosendans, 15 parts of Semen Canavaliaes, 20 parts of Bulbus Allii Macrostemonis, 30 parts of Flos Loniceraes, 20 parts of Herba Violaes, 30 parts of Herba Taraxacis, 20 parts of Fructus Forsythiaes, 20 parts of Radix Scrophulariaes, 30 parts of Radix Rehmanniae, 30 parts of Radix Sophorae Flavescentiss, 30 parts of Radix Scutellariaes, 15 parts of Flos Chrysanthemis, 20 parts of Radix Bupleuri, 20 parts of Radix Puerariaes, 10 parts of Herba Menthaes, 20 parts of Fructus Arctiis, 50 parts of Gypsum Fibrosum, 20 parts of the Rhizoma Anemarrhenaes, 20 parts of Herba Lophatheris, 30 parts of Radix Trichosanthis, 20 parts of Radix Gentianaes, 30 parts of Herba Houttuyniae, 30 parts of Cortex Moutans, 20 parts of Radix Paeoniae Rubra, 15 parts of Rhizoma Paridis, 20 parts of Folium Isatidiss, 30 parts of Baphicacanthus cusia, 20 parts of Indigo Naturaliss, 20 parts of Herba Patriniae, 20 parts of Radix Sophorae Tonkinensiss, 30 parts of Rhizoma Smilacis Glabraes, 15 parts of Herba Andrographis, 15 parts of Herba Lobeliae Chinensis, 20 parts of Herba Hedyotidis Diffusaes.
Each raw material of above-mentioned weight portion is mixed, after grinding into fine powder and crossing 800～1200 order dusting covers, make tablet promptly.
The preparation of [embodiment 4] pill
Take by weighing each raw material by following weight portion: 15 parts of Rhizoma Belamcandae, 30 parts of Fructus Aurantii Immaturuss, 10 parts of Lignum Aquilariae Resinatum, 20 parts of Rhizoma Chuanxiongs, 30 parts on Pericarpium Citri Reticulatae Viride, 50 parts of Pericarpium Citri Reticulataes, 20 parts of the Radix Aucklandiae, 20 parts of Semen Raphanis, 30 parts of Fructus Toosendans, 15 parts of Semen Canavaliaes, 20 parts of Bulbus Allii Macrostemonis, 30 parts of Flos Loniceraes, 20 parts of Herba Violaes, 30 parts of Herba Taraxacis, 20 parts of Fructus Forsythiaes, 20 parts of Radix Scrophulariaes, 30 parts of Radix Rehmanniae, 30 parts of Radix Sophorae Flavescentiss, 30 parts of Radix Scutellariaes, 15 parts of Flos Chrysanthemis, 20 parts of Radix Bupleuri, 20 parts of Radix Puerariaes, 10 parts of Herba Menthaes, 20 parts of Fructus Arctiis, 50 parts of Gypsum Fibrosum, 20 parts of the Rhizoma Anemarrhenaes, 20 parts of Herba Lophatheris, 30 parts of Radix Trichosanthis, 20 parts of Radix Gentianaes, 30 parts of Herba Houttuyniae, 30 parts of Cortex Moutans, 20 parts of Radix Paeoniae Rubra, 15 parts of Rhizoma Paridis, 20 parts of Folium Isatidiss, 30 parts of Baphicacanthus cusia, 20 parts of Indigo Naturaliss, 20 parts of Herba Patriniae, 20 parts of Radix Sophorae Tonkinensiss, 30 parts of Rhizoma Smilacis Glabraes, 15 parts of Herba Andrographis, 15 parts of Herba Lobeliae Chinensis, 20 parts of Herba Hedyotidis Diffusaes.
Each raw material of above-mentioned weight is mixed, grind into cross 600～1000 mesh sieves behind the fine powder after, make pill promptly.
The preparation of [embodiment 5] oral liquid
Take by weighing each raw material by following weight portion:
Each raw material of above-mentioned weight is mixed, after three decoctions, three filtrates are mixed, filter, be concentrated into
Normal concentration, put cold, the stock solution embedding, irradiation sterilization, after the check, packed products is made oral liquid promptly.
[experimental example] traditional Chinese medicine composition for treating tonsillitis of the present invention patient's clinical observation on the therapeutic effect experiment
One, the physical data of experimental subject: adopt Chinese medicine composition of the present invention to treat 23 routine patients altogether, wherein male 13 examples, women 9 examples; The oldest person 68 years old, the age reckling has only 1.3 years old.
Two, Therapeutic Method:
Usage and dosage: adopt the prepared medicament of the embodiment of the invention, its usage and consumption are as follows: 1) capsule: obey 2～5 every day three times at every turn, and every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2～4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 5 grams, warm water takes.4) granule: every day three times.Each 5 grams, warm water takes.
The course of treatment: one month is a course of treatment, treats for 3 courses of treatment altogether.
Three, therapeutic evaluation standard
Cure: sign and symptom are improved fully, and be happy, in high spirits.
Produce effects: sign and symptom are significantly improved, and be happy, and spirit is fine.
Effectively: sign and symptom change, and random thoughts have discomfort slightly, but can accept.
Invalid: sign does not have change, symptom such as preceding.
Four, model case:
1, Lee, woman, 26 years old.
Main suit: heating, pharyngalgia 4 days, dysphagia, rapid breathing 2 days.Occur heating after patient's readme was suffered from cold before 4 days, the body temperature of testing oneself reaches 39.5 ℃, adds azithromycin 0.5g intravenous drip in the local venoclysis normal saline 250ml of hospital, but never decline of body temperature, and symptoms such as dysphagia, rapid breathing appear.Subjective symptoms is serious, satisfies and comes emergency treatment.Have a medical check-up: T:40.1 ℃, face of acute ill, buccal is crimson, pharyngeal cavity hyperemia, the enlargement of two survey tonsil II degree, purulent secretion is seen on the surface.Cervical region, the angle of mandible lymphadenectasis is touched a tender spot.Yellow fur matter is red, full and rapid pulse.Diagnosis: acute tonsillitis.
Took Chinese medicine composition of the present invention 3, patient temperature begins after 24 hours to descend in medication, medication temperature recovery to 37 ℃ after 72 hours.Continue and obeyed Chinese medicine composition of the present invention 15, patient's pharyngalgia transference cure, 36.5 ℃ of body temperature.Obeyed Chinese medicine composition of the present invention again 1 month, every sign is normal, patient's recovery from illness.
2, surplus so-and-so, man, 11 years old.
Main suit: heating, throat pain, dysphagia 3 days.The patient has injected the penicillin injection treatment of promptly bringing down a fever, and symptom fails to alleviate, so the traditional Chinese medical science of seeing a doctor.Have a medical check-up: T:39.5 ° of C, the enlargement of tonsil III degree.Red tongue, yellow fur is thick, full and rapid pulse.
Took Chinese medicine composition of the present invention 3,38 ° of C are reduced in the i.e. decline gradually of body temperature on the same day of taking medicine night, and next day, body temperature was reduced to normally, and throat pain is eliminated substantially, and the 3rd quotidian fever, pharyngalgia symptom all disappear.Continue and obeyed Chinese medicine composition of the present invention 15, patient's recovery from illness.
3, the king so-and-so, woman, 35 years old.
The main suit: pharyngalgia show effect repeatedly 2 years surplus.Occur pharyngalgia, pharynx foreign body sensation after the patient suffered from cold before 2 years, do not have cough, the state of an illness is shown effect repeatedly over 2 years, the heat that occurs together sometimes, give anti-inflammatory treatment after symptom take a turn for the better, but can not eradicate.Recently outbreak once more, dryness of the mouth and throat, pharyngeal scorching hot hypodynia, foreign body sensation, body temperature is normal.Have a medical check-up: pharyngeal tonsils and rubescent all around, the enlargement of bilateral amygdala II degree is chronic congestion, the light red few tongue of body of the tongue, thready and rapid pulse.
Took Chinese medicine composition of the present invention 3, and told the pharyngeal pain on the secondth of taking medicine and significantly alleviate, the 3rd pharyngeal has not had obvious pain.Continue and obeyed Chinese medicine composition of the present invention 10, the pharyngalgia transference cure is checked and is seen pharyngeal nothing difference.Obeyed Chinese medicine composition of the present invention again 25, patient's recovery from illness.Followed up a case by regular visits to 1 year, and do not see recurrence.
4, Wang, man, 22 years old.
The main suit: pharyngalgia is violent, companion's dysphagia 3 days.The patient thought behind the blocked shot before three days that pharyngalgia is violent, dysphagia, and the self-induction thing is stifled, fever with chills, thirst with desire to drink, halitosis is hard and dry, red urine.Have a medical check-up: T:38.5 ° of C, slight chill, halitosis, thirst and desire for cold drink is checked and seen pharyngeal antiadoncus, and is little red, and pus is arranged, dysphagia, red tongue, yellow fur is thick, full and large pulse.
Took Chinese medicine composition of the present invention 5, the red swelling of the pharynx phenomenon disappears, and pain symptom obviously improves, and all the other symptoms greatly take a turn for the better.The clothes Chinese medicine composition of the present invention that continues was consolidated 30, patient's recovery from illness.Follow up a case by regular visits to after half a year, the patient is recurrence more not.
5, Huang, man, 17 years old.
The main suit: pharyngeal seemingly have thing to stop up sense, nearly two weeks of hypodynia.Two weeks of patient, pharyngeal obstruction sense appearred in preceding no obvious inducement, hypodynia, and with dry mouth and throat, dry cough, feverish sensation in the palms and soles.Have a medical check-up: there is not heating, deficiency of QI with disinclination to talk, tongue is few, red tongue, thready and rapid pulse.
Took Chinese medicine composition of the present invention 5, dry pharynx pharyngalgia symptom has clear improvement, and dry cough reduces.Continue and obeyed Chinese medicine composition of the present invention 15, pharyngeal comfortable, there is not the sense of obstruction, feverish sensation in the palms and soles, the transference cure of breathing hard.Continue again and obeyed Chinese medicine composition of the present invention 1 month, patient's recovery from illness.Follow up a case by regular visits to after half a year, this disease of patient is recurrence more not.
6, Chen, man, 8 years old.
Main suit: pharyngeal pain, companion's 2 weeks of dysphagia.Infant 2 all cause flu cause pharyngeal pain, more so, are radiated to ear when swallowing, and hyperpyrexia is not still felt any better behind the doctor trained in Western medicine infusion treatment, dysphagia, big dry stool.Have a medical check-up: T:39.0 ° of C, the pharyngeal tonsils redness can be touched the lymph node of enlargement under the jaw, red tongue, yellow fur, full and large pulse and counting.
Took Chinese medicine composition of the present invention 5, infant feels that pharyngeal pain symptom alleviates.Continue and obeyed Chinese medicine composition of the present invention 10, the infant symptom disappears substantially.Obeyed Chinese medicine composition of the present invention again 15, red swelling of the pharynx disappears, recovery from illness.Follow up a case by regular visits to after three months, infant tonsil symptom is not seen recurrence.
7, Bai, woman, 11 years old.
Main suit: suffer from allergic rhinitis, repeated cold, tonsillitis 6 years.Patient's repeated cold, caught a cold once in a left side in 8-15 days, flu one outbreak, the tonsillitis outbreak, pharyngalgia, cough, expectoration, cough is serious sometimes, heat, headache, sneeze occur together, rhinorrhea shows effect throughout the year, has daytime and night to perspire, and xerostomia dry pharynx, pharyngalgia, nasal cavity are itched, eyes are itched, nasal obstruction, dyspnea sensation, low hotness, lassitude, appetite is general, and the urine stool is normal.Have a medical check-up: the pale swelling of two nasal mucosas, pharyngeal diffusivity hyperemia, antiadoncus III degree, congested, adularescent pus point, mandibular lymph node enlargement.The light red few tongue of body of the tongue, thready and rapid pulse without strength.
Took Chinese medicine composition of the present invention 10, and told flu and reduce, pharyngalgia sx during outbreak, sneeze, flowing water sample nasal mucus reduce, and perspire at daytime and night and take a turn for the better, and cough alleviates, and spirit is normal, and the food drink is normal.Check that two nasal mucosas are pale, pharyngeal hyperemia, the hyperemia of antiadoncus III degree, pus point disappearance, the state of an illness is tentatively controlled.The clothes Chinese medicine composition of the present invention that continues was consolidated 15, and patient's body constitution is good, seldom flu.Obeyed Chinese medicine composition of the present invention again 15, acute rhinitis and tonsillitis are cured.Followed up a case by regular visits to 3 years, not recurrence.
8, Liu so-and-so, woman, 10 years old.
The main suit: suppurative tonsillitis, antiadoncus II degree, sick time 2 years is surplus.The patient is in the time in 2 years, and just have a fever 1-2 time average every month, and tonsil infection suppurates, and all is that transfusion is kept at every turn, but just shows effect once again every about 7-15 days, has had a strong impact on patient's growth promoter and physical and mental health.Have a medical check-up: patient's limbs fatigue, mental weariness, the light red few tongue of body of the tongue, thready and rapid pulse.
Took Chinese medicine composition of the present invention 10, infant spirit takes a turn for the better, and tonsil becomes the I degree by the atrophy of II degree, no pus point, little hyperemia.Continue and obeyed Chinese medicine composition of the present invention 15, the throat symptom all disappears.The clothes Chinese medicine composition of the present invention that continues was consolidated 15, patient's recovery from illness.Followed up a case by regular visits to 3 years, not recurrence again.
Five, therapeutic outcome:
In the 23 routine cases of being accepted for medical treatment,, wherein cure 5 examples through treatment in 3 months, produce effects 7 examples, effective 9 examples, invalid 2 examples, total effective rate reaches 91%.The result shows that Chinese medicine composition of the present invention has extremely significant curative effect to treatment tonsillitis patient.
Claims (7)
1. treat tonsillitic Chinese medicine composition for one kind, it is characterized in that: mainly contain following bulk drugs and form:
1～50 part of Rhizoma Belamcandae, 1～150 part of Fructus Aurantii Immaturus, 1～50 part of Lignum Aquilariae Resinatum, 1～50 part of Rhizoma Chuanxiong, 1～100 part on Pericarpium Citri Reticulatae Viride, 1～150 part of Pericarpium Citri Reticulatae, 1～100 part of the Radix Aucklandiae, 1～120 part of Semen Raphani, 1～120 part of Fructus Toosendan, 1～50 part of Semen Canavaliae, 1～100 part of Bulbus Allii Macrostemonis, 1～120 part of Flos Lonicerae, 1～100 part of Herba Violae, 1～120 part of Herba Taraxaci, 1～100 part of Fructus Forsythiae, 1～100 part of Radix Scrophulariae, 1～120 part of Radix Rehmanniae, 1～100 part of Radix Sophorae Flavescentis, 1～120 part of Radix Scutellariae, 1～50 part of Flos Chrysanthemi, 1～100 part of Radix Bupleuri, 1～100 part of Radix Puerariae, 1～30 part of Herba Menthae, 1～100 part of Fructus Arctii, 1～120 part of Gypsum Fibrosum, 1～100 part of the Rhizoma Anemarrhenae, 1～100 part of Herba Lophatheri, 1～120 part of Radix Trichosanthis, 1～100 part of Radix Gentianae, 1～120 part of Herba Houttuyniae, 1～120 part of Cortex Moutan, 1～100 part of Radix Paeoniae Rubra, 1～50 part of Rhizoma Paridis, 1～100 part of Folium Isatidis, 1～100 part of Radix Isatidis, 1～100 part of Indigo Naturalis, 1～100 part of Herba Patriniae, 1～100 part of Radix Sophorae Tonkinensis, 1～120 part of Rhizoma Smilacis Glabrae, 1～50 part of Herba Andrographis, 1～50 part of Herba Lobeliae Chinensis, 1～100 part of Herba Hedyotidis Diffusae.
2. according to the described Chinese medicine composition of claim 1, it is characterized in that: the weight portion of each crude drug is:
15 parts of Rhizoma Belamcandae, 30 parts of Fructus Aurantii Immaturuss, 10 parts of Lignum Aquilariae Resinatum, 20 parts of Rhizoma Chuanxiongs, 30 parts on Pericarpium Citri Reticulatae Viride, 50 parts of Pericarpium Citri Reticulataes, 20 parts of the Radix Aucklandiae, 20 parts of Semen Raphanis, 30 parts of Fructus Toosendans, 15 parts of Semen Canavaliaes, 20 parts of Bulbus Allii Macrostemonis, 30 parts of Flos Loniceraes, 20 parts of Herba Violaes, 30 parts of Herba Taraxacis, 20 parts of Fructus Forsythiaes, 20 parts of Radix Scrophulariaes, 30 parts of Radix Rehmanniae, 30 parts of Radix Sophorae Flavescentiss, 30 parts of Radix Scutellariaes, 15 parts of Flos Chrysanthemis, 20 parts of Radix Bupleuri, 20 parts of Radix Puerariaes, 10 parts of Herba Menthaes, 20 parts of Fructus Arctiis, 50 parts of Gypsum Fibrosum, 20 parts of the Rhizoma Anemarrhenaes, 20 parts of Herba Lophatheris, 30 parts of Radix Trichosanthis, 20 parts of Radix Gentianaes, 30 parts of Herba Houttuyniae, 30 parts of Cortex Moutans, 20 parts of Radix Paeoniae Rubra, 15 parts of Rhizoma Paridis, 20 parts of Folium Isatidiss, 30 parts of Baphicacanthus cusia, 20 parts of Indigo Naturaliss, 20 parts of Herba Patriniae, 20 parts of Radix Sophorae Tonkinensiss, 30 parts of Rhizoma Smilacis Glabraes, 15 parts of Herba Andrographis, 15 parts of Herba Lobeliae Chinensis, 20 parts of Herba Hedyotidis Diffusaes.
3. according to the described Chinese medicine composition of claim 1, wherein crude drug also has:
1～50 part of Radix Cynanchi Atrati, 1～120 part of Cortex Lycii, 1～100 part of Radix Stellariae, 1～100 part of Rhizoma Picrorhizae, 1～100 part of Radix Et Rhizoma Rhei, 1～100 part of Semen Pruni, 1～100 part of Radix Curcumae, 1～50 part of rhizoma sparganic, 1～50 part of Rhizoma Curcumae, 1～50 part of Squama Manis, 1～50 part of Carapax Trionycis, 1～50 part of Carapax et Plastrum Testudinis, 1～120 part of Semen Trichosanthis, 1～30 part of Bulbus Fritillariae Uninbracteatae, 1～100 part of the Radix Paeoniae Alba, 1～100 part of Radix Angelicae Sinensis, 1～120 part of Radix Adenophorae (Radix Glehniae), 1～100 part of Radix Ophiopogonis, 1～100 part of Radix Asparagi, 1～100 part of Fructus Lycii, 1～50 part of Herba Dendrobii, 1～50 part of Rhizoma Polygonati Odorati.
4. according to the described Chinese medicine composition of claim 3, wherein the weight portion of each component is:
15 parts of Radix Cynanchi Atratis, 30 parts of Cortex Lycii, 20 parts of Radix Stellariaes, 20 parts of Rhizoma Picrorhizae, 20 parts of Radix Et Rhizoma Rhei, 20 parts of Semen Prunis, 20 parts of Radix Curcumaes, 15 parts of rhizoma sparganic, 15 parts of Rhizoma Curcumae, 15 parts of Squama Maniss, 15 parts of Carapax Trionycis, 15 parts of Carapax et Plastrum Testudiniss, 30 parts of Semen Trichosanthis, 10 parts of Bulbus Fritillariae Uninbracteataes, 30 parts of the Radix Paeoniae Albas, 30 parts of Radix Angelicae Sinensis, 30 parts of Radix Adenophorae (Radix Glehniae), 20 parts of Radix Ophiopogonis, 20 parts of Radix Asparagi, 20 parts of Fructus Lycii, 15 parts of Herba Dendrobiis, 15 parts of Rhizoma Polygonati Odorati.
5. according to claim 1,2,3 or 4 described any Chinese medicine compositions, it is characterized in that: can be prepared into any oral formulations commonly used according to the method for Chinese medicinal of routine.
6. according to the described Chinese medicine composition of claim 5, it is characterized in that: described oral formulations is pill, capsule, tablet, powder, granule or oral liquid.
7. the application of the described any Chinese medicine composition of claim 1～6 in preparation treatment tonsillitis medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101899632A CN101816757B (en) | 2010-06-02 | 2010-06-02 | Chinese medicinal composition for treating antiaditis and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101899632A CN101816757B (en) | 2010-06-02 | 2010-06-02 | Chinese medicinal composition for treating antiaditis and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101816757A true CN101816757A (en) | 2010-09-01 |
| CN101816757B CN101816757B (en) | 2012-04-18 |
Family
ID=42652134
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101899632A Expired - Fee Related CN101816757B (en) | 2010-06-02 | 2010-06-02 | Chinese medicinal composition for treating antiaditis and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101816757B (en) |
Cited By (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102133348A (en) * | 2011-02-28 | 2011-07-27 | 辛如才 | Traditional Chinese medicine for treating scarflet fever |
| CN102178864A (en) * | 2011-05-27 | 2011-09-14 | 吴伶 | Chinese medicinal oral liquid for treating amygdalitis |
| CN102343034A (en) * | 2011-10-14 | 2012-02-08 | 李泽琳 | Composition applied to side effects caused by tumor radiation and pharyngitis |
| CN102462827A (en) * | 2011-04-20 | 2012-05-23 | 吴秀友 | Traditional Chinese medicinal powder formulation for treating postpartum mastitis of Boer goat |
| CN102488834A (en) * | 2011-12-12 | 2012-06-13 | 张永扬 | Medicament for treating acute upper respiratory tract infection |
| CN102670870A (en) * | 2012-05-28 | 2012-09-19 | 张艳 | Chinese herb preparation for curing acute suppurative tonsillitis of children |
| CN102727825A (en) * | 2012-06-20 | 2012-10-17 | 葛文农 | Oral medicine used for treating tonsillitis |
| CN103041129A (en) * | 2013-02-02 | 2013-04-17 | 崔合芳 | Traditional Chinese medicine composition for treating pneumonia |
| CN103071056A (en) * | 2013-01-09 | 2013-05-01 | 普洱市民族传统医药研究所 | Medicine for curing oral diseases |
| CN103127410A (en) * | 2013-02-19 | 2013-06-05 | 陈曦萌 | Traditional Chinese medicine composition used for treating oral ulcer |
| CN103230569A (en) * | 2013-04-25 | 2013-08-07 | 袁建国 | Traditional Chinese medicine preparation for treating parotitis |
| CN103341068A (en) * | 2013-07-16 | 2013-10-09 | 洪满 | Traditional Chinese medicine composition for treating amygdalitis |
| CN103405739A (en) * | 2013-08-23 | 2013-11-27 | 杨艳 | Medicine for treating infant suppurative tonsillitis |
| CN103550487A (en) * | 2013-10-29 | 2014-02-05 | 金福娥 | Traditional Chinese medicine fluid for treating chronic laryngitis |
| CN103690781A (en) * | 2013-12-18 | 2014-04-02 | 孙斌 | Traditional Chinese medicine for treating erosive acute amygdalitis |
| CN103721126A (en) * | 2013-10-23 | 2014-04-16 | 青岛华仁技术孵化器有限公司 | Traditional Chinese medicine composition for treating chronic pharyngitis |
| CN103735773A (en) * | 2014-01-24 | 2014-04-23 | 辛丽梅 | Traditional Chinese medicinal preparation for treating tonsil inflammation and preparation method thereof |
| CN104013790A (en) * | 2014-05-28 | 2014-09-03 | 李大波 | Traditional Chinese medicine preparation for treating chronic suppurative tonsillitis |
| CN104306777A (en) * | 2014-11-04 | 2015-01-28 | 禤燕华 | Traditional Chinese medicine combination for curing acute tonsillitis |
| CN104547279A (en) * | 2015-01-29 | 2015-04-29 | 王修丽 | Traditional Chinese medicine for treating heat toxin qi stagnation type acute tonsillitis |
| CN104587268A (en) * | 2015-02-09 | 2015-05-06 | 高金梅 | Traditional Chinese medicine preparation for treating yin-deficiency heat-invasion type acute tonsillitis |
| CN104740277A (en) * | 2015-03-06 | 2015-07-01 | 姜新帅 | Traditional Chinese medicine composition for treating tonsillitis |
| CN105031531A (en) * | 2015-07-31 | 2015-11-11 | 青岛海之星生物科技有限公司 | Spray for treating children acute suppurative tonsillitis and preparation method thereof |
| CN105055841A (en) * | 2015-09-01 | 2015-11-18 | 吉林大学 | Medicine for treating chronic pharyngitis and preparing method thereof |
| CN106177778A (en) * | 2016-08-23 | 2016-12-07 | 赵乾妤 | A kind of externally applied ointment treating chronic tonsillitis and pharyngitis |
| CN106309713A (en) * | 2016-09-22 | 2017-01-11 | 张新雨 | Traditional Chinese medicine recipe for treating amygdalitis |
| WO2020029151A1 (en) * | 2018-08-09 | 2020-02-13 | 蔡进 | Fabric for preventing tonsillitis |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1235032A (en) * | 1998-05-09 | 1999-11-17 | 张玉国 | Chinese medicine for tonsillitis and laryngopharyngitis |
| CN1404853A (en) * | 2002-01-18 | 2003-03-26 | 陈炳南 | Medicine for treating tonsillitis and laryngopharyngitis |
-
2010
- 2010-06-02 CN CN2010101899632A patent/CN101816757B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1235032A (en) * | 1998-05-09 | 1999-11-17 | 张玉国 | Chinese medicine for tonsillitis and laryngopharyngitis |
| CN1404853A (en) * | 2002-01-18 | 2003-03-26 | 陈炳南 | Medicine for treating tonsillitis and laryngopharyngitis |
Non-Patent Citations (1)
| Title |
|---|
| 《中药别名速查大辞典》 19970331 李顺保 板蓝 1120 1-7 , 1 * |
Cited By (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102133348A (en) * | 2011-02-28 | 2011-07-27 | 辛如才 | Traditional Chinese medicine for treating scarflet fever |
| CN102133348B (en) * | 2011-02-28 | 2012-07-25 | 辛如才 | Traditional Chinese medicine for treating scarflet fever |
| CN102462827A (en) * | 2011-04-20 | 2012-05-23 | 吴秀友 | Traditional Chinese medicinal powder formulation for treating postpartum mastitis of Boer goat |
| CN102178864A (en) * | 2011-05-27 | 2011-09-14 | 吴伶 | Chinese medicinal oral liquid for treating amygdalitis |
| CN102178864B (en) * | 2011-05-27 | 2012-05-23 | 吴伶 | Chinese medicinal oral liquid for treating amygdalitis |
| CN102343034A (en) * | 2011-10-14 | 2012-02-08 | 李泽琳 | Composition applied to side effects caused by tumor radiation and pharyngitis |
| CN102488834A (en) * | 2011-12-12 | 2012-06-13 | 张永扬 | Medicament for treating acute upper respiratory tract infection |
| CN102670870A (en) * | 2012-05-28 | 2012-09-19 | 张艳 | Chinese herb preparation for curing acute suppurative tonsillitis of children |
| CN102727825A (en) * | 2012-06-20 | 2012-10-17 | 葛文农 | Oral medicine used for treating tonsillitis |
| CN102727825B (en) * | 2012-06-20 | 2013-09-25 | 陈霞 | Oral medicine used for treating tonsillitis |
| CN103071056A (en) * | 2013-01-09 | 2013-05-01 | 普洱市民族传统医药研究所 | Medicine for curing oral diseases |
| CN103041129A (en) * | 2013-02-02 | 2013-04-17 | 崔合芳 | Traditional Chinese medicine composition for treating pneumonia |
| CN103041129B (en) * | 2013-02-02 | 2014-07-23 | 崔合芳 | Traditional Chinese medicine composition for treating pneumonia |
| CN103127410A (en) * | 2013-02-19 | 2013-06-05 | 陈曦萌 | Traditional Chinese medicine composition used for treating oral ulcer |
| CN103230569A (en) * | 2013-04-25 | 2013-08-07 | 袁建国 | Traditional Chinese medicine preparation for treating parotitis |
| CN103341068A (en) * | 2013-07-16 | 2013-10-09 | 洪满 | Traditional Chinese medicine composition for treating amygdalitis |
| CN103405739B (en) * | 2013-08-23 | 2015-08-05 | 杨艳 | A kind of medicine for the treatment of children's's suppurative tonsillitis |
| CN103405739A (en) * | 2013-08-23 | 2013-11-27 | 杨艳 | Medicine for treating infant suppurative tonsillitis |
| CN103721126A (en) * | 2013-10-23 | 2014-04-16 | 青岛华仁技术孵化器有限公司 | Traditional Chinese medicine composition for treating chronic pharyngitis |
| CN103721126B (en) * | 2013-10-23 | 2017-02-08 | 吉林大学 | Traditional Chinese medicine composition for treating chronic pharyngitis |
| CN103550487A (en) * | 2013-10-29 | 2014-02-05 | 金福娥 | Traditional Chinese medicine fluid for treating chronic laryngitis |
| CN103550487B (en) * | 2013-10-29 | 2015-06-24 | 金福娥 | Traditional Chinese medicine fluid for treating chronic laryngitis |
| CN103690781A (en) * | 2013-12-18 | 2014-04-02 | 孙斌 | Traditional Chinese medicine for treating erosive acute amygdalitis |
| CN103690781B (en) * | 2013-12-18 | 2015-12-02 | 烟台瑞智生物医药科技有限公司 | A kind of Chinese medicine for the treatment of erosive type acute tonsillitis |
| CN103735773A (en) * | 2014-01-24 | 2014-04-23 | 辛丽梅 | Traditional Chinese medicinal preparation for treating tonsil inflammation and preparation method thereof |
| CN103735773B (en) * | 2014-01-24 | 2016-03-23 | 展爱杰 | A kind of Chinese medicine preparation and preparation method for the treatment of tonsil inflammation |
| CN104013790A (en) * | 2014-05-28 | 2014-09-03 | 李大波 | Traditional Chinese medicine preparation for treating chronic suppurative tonsillitis |
| CN104306777A (en) * | 2014-11-04 | 2015-01-28 | 禤燕华 | Traditional Chinese medicine combination for curing acute tonsillitis |
| CN104547279A (en) * | 2015-01-29 | 2015-04-29 | 王修丽 | Traditional Chinese medicine for treating heat toxin qi stagnation type acute tonsillitis |
| CN104587268A (en) * | 2015-02-09 | 2015-05-06 | 高金梅 | Traditional Chinese medicine preparation for treating yin-deficiency heat-invasion type acute tonsillitis |
| CN104740277A (en) * | 2015-03-06 | 2015-07-01 | 姜新帅 | Traditional Chinese medicine composition for treating tonsillitis |
| CN105031531A (en) * | 2015-07-31 | 2015-11-11 | 青岛海之星生物科技有限公司 | Spray for treating children acute suppurative tonsillitis and preparation method thereof |
| CN105055841A (en) * | 2015-09-01 | 2015-11-18 | 吉林大学 | Medicine for treating chronic pharyngitis and preparing method thereof |
| CN106177778A (en) * | 2016-08-23 | 2016-12-07 | 赵乾妤 | A kind of externally applied ointment treating chronic tonsillitis and pharyngitis |
| CN106309713A (en) * | 2016-09-22 | 2017-01-11 | 张新雨 | Traditional Chinese medicine recipe for treating amygdalitis |
| WO2020029151A1 (en) * | 2018-08-09 | 2020-02-13 | 蔡进 | Fabric for preventing tonsillitis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101816757B (en) | 2012-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101816757B (en) | Chinese medicinal composition for treating antiaditis and preparation method thereof | |
| CN101780237B (en) | Traditional Chinese medicine composition for treating cough and preparation method thereof | |
| CN101810799B (en) | Chinese medicinal composition for treating eruption and preparation method thereof | |
| CN101757542B (en) | Traditional Chinese medicine composition for treating colonitis and preparation method | |
| CN101766804B (en) | Chinese herbal composite for epistaxis treatment and preparation method thereof | |
| CN101757403B (en) | Traditional Chinese medicine composition for treating acute nephritis and preparation method thereof | |
| CN101869691B (en) | Chinese medicinal composition for treating dysmenorrhea and preparation method thereof | |
| CN101693089B (en) | Traditional Chinese medicine compound for treating diseases of lung Qi obstruction and dyspnea chest discomfort and preparation method thereof | |
| CN101816763A (en) | Chinese medicament for treating chronic pharyngitis and preparation method thereof | |
| CN101766791A (en) | Chinese herbal composite for fever treatment and preparation method thereof | |
| CN101856459B (en) | Chinese medicinal composition for treating lung carbunculosis and preparation method thereof | |
| CN101966301A (en) | Chinese medicinal composition for treating pelvic inflammation and preparation method thereof | |
| CN101757566A (en) | Traditional Chinese medicine composition for treating colon cancer and preparation method thereof | |
| CN101829293A (en) | Traditional Chinese medicine composite for treating cough disease and preparation method thereof | |
| CN101670055A (en) | Traditional Chinese medicine composition for treating disease of pyelonephritis and preparation method | |
| CN101785845A (en) | Traditional Chinese medicine combination and preparation method for intestinal flatulence treatment | |
| CN101766802A (en) | Chinese medicine composite for treatment of acute gastroenteritis and preparation method thereof | |
| CN101773634A (en) | Chinese medicine composition for treating abdominal distention and fullness and preparation method thereof | |
| CN101785819B (en) | Traditional Chinese medicine combination and preparation method thereof for hydrothorax treatment | |
| CN101843882B (en) | Chinese medicinal composition for treating cholecystitis diseases and preparation method thereof | |
| CN101829267B (en) | Traditional Chinese medicine combination for treating lung asthma and preparation method thereof | |
| CN101829296B (en) | Traditional Chinese medicine combination for treating pulmonary atelectasis and preparation method thereof | |
| CN101780228B (en) | Traditional Chinese medicine composition for treating tinnitus and preparation method thereof | |
| CN101837113A (en) | Chinese medicinal composition for curing fever during menstruation and preparation method thereof | |
| CN101829308A (en) | Traditional Chinese medicine combination for treating amenorrhea and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120418 Termination date: 20130602 |